Cumulative Royalties. The obligation to pay Royalties under this Article 4 shall be imposed only once (i) with respect to any sale of the same unit of Product and (ii) with respect to a single unit of Product, in each case, regardless of how many Valid Claims in the Neurocrine Patent Rights or Program Patent Rights cover the Compound included in such Product.
Appears in 4 contracts
Samples: Collaboration Agreement (Neurocrine Biosciences Inc), Collaboration Agreement, Collaboration Agreement (Neurocrine Biosciences Inc)
